Article
Federal Circuit Reverses $4.7M Verdict In Labcorp V. QIAGEN: Claim Scope And Doctrine Of Equivalents In The Crosshairs
The Federal Circuit recently reversed a $4.7M verdict in a patent lawsuit involving two patents concerning next-generation sequencing methods—U.S. Patent Nos. 10,017,810 and 10,450,597.
Proskauer Rose LLP